Novavax CEO: ‘We are making an Omicron variant strain vaccine’

Novavax CEO Stanley Erck joins Yahoo Finance’s Anjalee Khemlani and Akiko Fujita to discuss the efficacy of the company’s COVID vaccine against the Omicron variant, global production and distribution of vaccines, and the pathway for FDA authorization.